vimarsana.com

Page 3 - Dexcom Share News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DexCom, Inc (NASDAQ:DXCM) EVP Michael Jon Brown Sells 652 Shares of Stock

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Michael Jon Brown sold 652 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $119.24, for a total value of $77,744.48. Following the transaction, the executive vice president now owns 67,560 shares of the company’s […]

29,073 Shares in DexCom, Inc (NASDAQ:DXCM) Bought by Evoke Wealth LLC

Evoke Wealth LLC acquired a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 29,073 shares of the medical device company’s stock, valued at approximately $3,608,000. A number of other […]

United Services Automobile Association Acquires New Position in DexCom, Inc (NASDAQ:DXCM)

United Services Automobile Association acquired a new stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,036 shares of the medical device company’s stock, valued at approximately $1,369,000. Several […]

United Services Automobile Association Takes Position in DexCom, Inc (NASDAQ:DXCM)

United Services Automobile Association bought a new stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 11,036 shares of the medical device company’s stock, valued at approximately $1,369,000. Several other large investors have also recently […]

DexCom (NASDAQ:DXCM) Downgraded by StockNews com

StockNews.com downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research note published on Saturday. A number of other research firms have also recently issued reports on DXCM. Raymond James boosted their target price on DexCom from $151.00 to $160.00 and gave the company a strong-buy […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.